ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,104 | -26.7% | 2,872 | +14.9% | 0.00% | – |
| Q2 2023 | $12,425 | -0.6% | 2,500 | -1.2% | 0.00% | – |
| Q1 2023 | $12,503 | -21.5% | 2,531 | 0.0% | 0.00% | – |
| Q4 2022 | $15,920 | -41.0% | 2,531 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | -6.9% | 2,531 | 0.0% | 0.00% | – |
| Q2 2022 | $29,000 | +7.4% | 2,531 | -15.1% | 0.00% | – |
| Q1 2022 | $27,000 | -38.6% | 2,981 | +0.6% | 0.00% | – |
| Q4 2021 | $44,000 | -42.1% | 2,964 | +0.5% | 0.00% | – |
| Q3 2021 | $76,000 | -1.3% | 2,950 | -0.6% | 0.00% | – |
| Q2 2021 | $77,000 | -26.0% | 2,969 | +0.6% | 0.00% | – |
| Q1 2021 | $104,000 | +40.5% | 2,950 | 0.0% | 0.00% | – |
| Q4 2020 | $74,000 | -33.3% | 2,950 | 0.0% | 0.00% | – |
| Q3 2020 | $111,000 | +3.7% | 2,950 | +18.0% | 0.00% | – |
| Q2 2020 | $107,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |